Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations - Concepedia

Concepedia

Publication | Open Access

Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations

DOI Full Paper Access

13

Citations

10

References

2022

Year

Xile Liu, Lu Zhang, Haiwen Wan, Zhenzhen Zhu, Jing Jin, Yuxin Qin, Weifeng Mao, Kang Yan, Douglas D. Fang, Wen Jiang,

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistryMedicinePreclinical EvaluationsNovel Alk InhibitorCrizotinib-resistant MutationsAnti-cancer AgentSystems BiologyPharmacologyNovel TherapyDrug Discovery

References

	Year	Citations

Page 1

Page 1